Part II: Genus-Specie Disputes: Thoughts on the Risdiplam Division Bench Judgment
Continuing the discussion on the Delhi High Court’s DB judgment in Risdiplam case, Part II of the post by Dr. Victor Vaibhav Tandon discusses the Court’s finding on the “Person in the Know” yardstick to assess obviousness and the comeback of public interest in high stakes pharma patent cases. Dr. Tandon is an academician turned lawyer, with the law firm Saikrishna and Associates. He continues to teach patent law- rather sporadically- at ILI and ISIL. The views expressed herein are […]
Part II: Genus-Specie Disputes: Thoughts on the Risdiplam Division Bench Judgment Read More »









